659. Can Marty Makary Fix the F.D.A.? - Freakonomics Radio Recap

Podcast: Freakonomics Radio

Published: 2026-01-16

Duration: 55 min

Summary

In this episode, Stephen Dubner explores the controversial changes at the FDA under Commissioner Marty Makary, touching on public health, vaccine recommendations, and the agency's evolving approach to regulation. Makary emphasizes the need for reform and challenges entrenched medical dogmas.

What Happened

The episode opens with a discussion of the FDA's current landscape, particularly under the leadership of Marty Makary, who has a background as a surgical oncologist and health policy researcher. Dubner highlights recent changes in health recommendations led by Secretary of Health and Human Services, Kennedy Jr., which have stirred controversy, especially regarding childhood vaccines and dietary guidelines. Makary's vision for the FDA includes a proactive approach to drug approvals and addressing the agency's historical challenges.

Makary reflects on his transition from a physician scientist to a government regulator, emphasizing the importance of questioning established norms and making data-driven decisions. He cites the modern peanut allergy epidemic as an example of how misguided medical advice—rooted in dogma rather than scientific evidence—can lead to unintended public health issues. He critiques the FDA's past decisions, particularly the approval of OxyContin, illustrating how regulatory bodies can sometimes become too aligned with the industries they oversee.

The conversation also delves into the FDA’s plans to revise the food pyramid, specifically addressing the long-standing biases against natural saturated fats and the impact of sugar on health. Makary's commitment to reform is evident as he aims to correct these misconceptions and promote a more scientifically sound understanding of nutrition. By sharing his insights and experiences, Makary provides a glimpse into the potential future of the FDA and its role in safeguarding public health.

Key Insights

• Marty Makary emphasizes the FDA's shift from a reactive to a proactive role in drug approvals.
• Historical medical dogmas can lead to significant public health issues, as seen with peanut allergies.
• The FDA's approval of OxyContin highlights the risks of regulatory capture by the pharmaceutical industry.
• Reforming dietary guidelines to reflect scientific evidence is a key focus for Makary's FDA.

Key Questions Answered

What changes has Marty Makary implemented at the FDA?

Marty Makary's approach at the FDA focuses on moving the agency from a reactive stance to a proactive one. He has emphasized the importance of seeking out promising developments in the pharmaceutical pipeline rather than waiting for applications to come in. This shift aims to facilitate quicker access to innovative treatments and improve public health outcomes.

How has the FDA responded to childhood vaccine recommendations?

Recently, Secretary of Health and Human Services, Kennedy Jr., has made significant alterations to vaccine recommendations, which has sparked debate. Makary's FDA is closely linked to these changes, as they reflect a broader strategy to reassess public health policies and ensure they are based on sound scientific evidence. This ongoing evolution in guidelines highlights the need for transparency and adaptability in public health strategies.

What lessons can be learned from the approval of OxyContin?

The approval of OxyContin stands as a cautionary tale for the FDA, illustrating how regulatory bodies can sometimes align too closely with the interests of the pharmaceutical industry. Makary critiques this moment in FDA history as emblematic of a time when the agency was 'captured' by those it was meant to regulate. This experience underscores the importance of rigorous oversight and a commitment to public health over industry pressures.

What is the significance of revising the food pyramid?

Makary's push to revise the food pyramid is significant as it aims to correct decades of misinformation about dietary fats and sugar. He argues that the medical community has mistakenly demonized natural saturated fats while ignoring the role of refined carbohydrates and added sugars in health issues. This revision seeks to better reflect current scientific understanding and promote healthier eating habits.

How does Marty Makary view his role in the Trump administration?

Though largely apolitical initially, Makary became involved with the Trump administration through his advocacy for healthcare transparency. His proposals for price transparency in hospitals were adopted by the administration, leading to significant regulatory changes. This experience has positioned him to influence health policy from within a government framework, aiming to implement ideas that could benefit public health.